Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score

Abstract Purpose Acute Kidney Injury (AKI) in COVID-19 patients is associated with increased morbidity and mortality. In the present study, we aimed to develop a prognostic score to predict AKI development in these patients. Materials and methods This was a retrospective observational study of 2334...

Full description

Bibliographic Details
Main Authors: Henrique Palomba, Daniel Cubos, Fernando Bozza, Fernando Godinho Zampieri, Thiago Gomes Romano
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Nephrology
Online Access:https://doi.org/10.1186/s12882-023-03095-4
_version_ 1797865365607284736
author Henrique Palomba
Daniel Cubos
Fernando Bozza
Fernando Godinho Zampieri
Thiago Gomes Romano
author_facet Henrique Palomba
Daniel Cubos
Fernando Bozza
Fernando Godinho Zampieri
Thiago Gomes Romano
author_sort Henrique Palomba
collection DOAJ
description Abstract Purpose Acute Kidney Injury (AKI) in COVID-19 patients is associated with increased morbidity and mortality. In the present study, we aimed to develop a prognostic score to predict AKI development in these patients. Materials and methods This was a retrospective observational study of 2334 COVID 19 patients admitted to 23 different hospitals in Brazil, between January 10th and August 30rd, 2020. The primary outcome of AKI was defined as any increase in serum creatinine (SCr) by 0.3 mg/dL within 48 h or a change in SCr by ≥ 1.5 times of baseline within 1 week, based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines. All patients aged ≥ 18 y/o admitted with confirmed SARS-COV-2 infection were included. Discrimination of variables was calculated by the Receiver Operator Characteristic Curve (ROC curve) utilizing area under curve. Some continuous variables were categorized through ROC curve. The cutoff points were calculated using the value with the best sensitivity and specificity. Results A total of 1131 patients with COVID-19 admitted to the ICU were included. Patients mean age was 52 ± 15,8 y/o., with a prevalence of males 60% (n = 678). The risk of AKI was 33% (n = 376), 78% (n = 293) of which did not require dialysis. Overall mortality was 11% (n = 127), while for AKI patients, mortality rate was 21% (n = 80). Variables selected for the logistic regression model and inclusion in the final prognostic score were the following: age, diabetes, ACEis, ARBs, chronic kidney disease and hypertension. Conclusion AKI development in COVID 19 patients is accurately predicted by common clinical variables, allowing early interventions to attenuate the impact of AKI in these patients.
first_indexed 2024-04-09T23:06:53Z
format Article
id doaj.art-ea5867be76334a6cac06844a23a46309
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-04-09T23:06:53Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-ea5867be76334a6cac06844a23a463092023-03-22T10:40:18ZengBMCBMC Nephrology1471-23692023-03-012411810.1186/s12882-023-03095-4Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI ScoreHenrique Palomba0Daniel Cubos1Fernando Bozza2Fernando Godinho Zampieri3Thiago Gomes Romano4Hospital Vila Nova Star – ICU and Critical Care Nephrology DepartmentHospital Vila Nova Star – ICU and Critical Care Nephrology DepartmentInstituto D’Or de Pesquisa e Ensino, Avenida República do Líbano 611Hospital Vila Nova Star – ICU and Critical Care Nephrology DepartmentHospital Vila Nova Star – ICU and Critical Care Nephrology DepartmentAbstract Purpose Acute Kidney Injury (AKI) in COVID-19 patients is associated with increased morbidity and mortality. In the present study, we aimed to develop a prognostic score to predict AKI development in these patients. Materials and methods This was a retrospective observational study of 2334 COVID 19 patients admitted to 23 different hospitals in Brazil, between January 10th and August 30rd, 2020. The primary outcome of AKI was defined as any increase in serum creatinine (SCr) by 0.3 mg/dL within 48 h or a change in SCr by ≥ 1.5 times of baseline within 1 week, based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines. All patients aged ≥ 18 y/o admitted with confirmed SARS-COV-2 infection were included. Discrimination of variables was calculated by the Receiver Operator Characteristic Curve (ROC curve) utilizing area under curve. Some continuous variables were categorized through ROC curve. The cutoff points were calculated using the value with the best sensitivity and specificity. Results A total of 1131 patients with COVID-19 admitted to the ICU were included. Patients mean age was 52 ± 15,8 y/o., with a prevalence of males 60% (n = 678). The risk of AKI was 33% (n = 376), 78% (n = 293) of which did not require dialysis. Overall mortality was 11% (n = 127), while for AKI patients, mortality rate was 21% (n = 80). Variables selected for the logistic regression model and inclusion in the final prognostic score were the following: age, diabetes, ACEis, ARBs, chronic kidney disease and hypertension. Conclusion AKI development in COVID 19 patients is accurately predicted by common clinical variables, allowing early interventions to attenuate the impact of AKI in these patients.https://doi.org/10.1186/s12882-023-03095-4
spellingShingle Henrique Palomba
Daniel Cubos
Fernando Bozza
Fernando Godinho Zampieri
Thiago Gomes Romano
Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
BMC Nephrology
title Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
title_full Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
title_fullStr Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
title_full_unstemmed Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
title_short Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
title_sort development of a risk score for aki onset in covid 19 patients cov aki score
url https://doi.org/10.1186/s12882-023-03095-4
work_keys_str_mv AT henriquepalomba developmentofariskscoreforakionsetincovid19patientscovakiscore
AT danielcubos developmentofariskscoreforakionsetincovid19patientscovakiscore
AT fernandobozza developmentofariskscoreforakionsetincovid19patientscovakiscore
AT fernandogodinhozampieri developmentofariskscoreforakionsetincovid19patientscovakiscore
AT thiagogomesromano developmentofariskscoreforakionsetincovid19patientscovakiscore